This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Wijk, J. P.H. Articles by Hoepelman, A. M. Search for Related Content PubMed PubMed Citation Articles by van Wijk, J. P.H. Articles by Hoepelman, A. M.

Functional and Structural Markers of Atherosclerosis in Human Immunodeficiency Virus-Infected Patients

Jeroen P.H. van Wijk, MD^_*,_*, Eelco J.P. de Koning, MD, PhD, Manuel Castro Cabezas, MD, PhD, Jorge Joven, MD, PhD, Jos op't Roodt, BSC, Ton J. Rabelink, MD, PhD and Andy M. Hoepelman, MD, PhD^_*

^_* Department of Internal Medicine and Infectious Disease, University Medical Center Utrecht, the Netherlands
Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands
Department of Internal Medicine, St. Franciscus Gasthuis, Rotterdam, the Netherlands
Centre de Recerca Biomèdica, Hospital Universitari de Sant Joan, Reus, Spain

View larger version (10K): [in a new window]   Figure 1 Mean flow-mediated vasodilation (FMD) (A), aortic pulse-wave velocity (PWV) (B), and carotid intima-media thickness (IMT) (C) in human immunodeficiency virus (HIV)-infected patients with the metabolic syndrome (MS+ group) and without the metabolic syndrome (MS– group), type 2 diabetic patients, and healthy controls. *p < 0.05 versus healthy controls. p < 0.05 versus type 2 diabetic patients. p < 0.05 versus MS– group. p < 0.05 versus MS+ group.